IMCC
Im Cannabis Corp
NASDAQ · Pharmaceuticals
$1.15
+0.02 (+1.77%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.19M | 4.60M | 5.55M |
| Net Income | 706.3K | 612.3K | 695.3K |
| EPS | — | — | — |
| Profit Margin | 13.6% | 13.3% | 12.5% |
| Rev Growth | +20.5% | +11.5% | +14.8% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 5.68M | 7.39M | 5.68M |
| Total Equity | 8.43M | 8.30M | 9.81M |
| D/E Ratio | 0.67 | 0.89 | 0.58 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.03M | 960.1K | 1.02M |
| Free Cash Flow | 306.9K | 405.9K | 317.4K |